Form 4: Xilio Therapeutics CEO Rene Russo Acquires 190,000 Stock Options
SEC Form 4 Filing
Rene Russo, CEO of Xilio Therapeutics, acquired 190,000 stock options on April 15, 2025, according to a recent SEC Form 4 filing.
Summary
- An SEC Form 4 filing reveals that Rene Russo, the President and CEO of Xilio Therapeutics, acquired 190,000 stock options on April 15, 2025.
- The exercise price of these options is $0.712.
- The options vest in equal monthly installments starting May 1, 2025, and continuing through April 1, 2029.
- The options expire on April 14, 2035.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. The sentiment is neither positive nor negative.
Positives
- The acquisition of stock options by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and equity ownership of company executives.
Stakeholder Impact
- Shareholders may view this as a sign of confidence from the CEO.
- Employees may see this as a positive indicator of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 04/15/2025 | Date of transaction: Rene Russo acquired 190,000 stock options. |
| 05/01/2025 | Vesting start date: Options vest in equal monthly installments beginning on this date. |
| 04/01/2029 | Vesting end date: Options vest in equal monthly installments ending on this date. |
| 04/14/2035 | Expiration date: Stock options expire on this date. |
| 04/16/2025 | Date of signature of the form. |
Keywords
Xilio Therapeutics, Rene Russo, stock options, SEC Form 4, insider trading, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.